Physician profile
Robert C Mooty
NPI 1730383423
$5,135.02
in general payments reported to CMS, 2019-2025
13 companies · $1,059 in 2025
The $1,059 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $93.62 · 2021: $499 · 2022: $951 · 2023: $1,162 · 2024: $941 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,161.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,884.56 | 2023-2025 | |
| Allergan, INC. | $1,769.32 | 2019-2022 | |
| Galderma Laboratories, L.P. | $161.68 | 2021-2024 | |
| Revance Therapeutics, INC. | $80.16 | 2025 | Daxxify |
| Coopersurgical, INC. | $68.71 | 2023-2024 | Summit Doppler, Supercut Hysterectomy Scissors |
| Tela Bio, INC. | $48.03 | 2020-2021 | |
| Sientra, INC. | $23.03 | 2021 | |
| Integra Lifesciences Corporation | $20.83 | 2020 | |
| Heron Therapeutics, INC. | $19.80 | 2022 | |
| Kerecis Limited | $17.43 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.58 | 2022 | |
| Innovation Technologies INC | $12.96 | 2021 | |
| Mallinckrodt Enterprises LLC | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mooty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.